Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
15 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Option traders are bracing for a big move in Micron Technology Inc. (NASDAQ: MU ) after Wednesday’s close. History suggests the bet may still be too small. According to Pro data, the option market implies a 6.3% move in either direction after Micron’s fiscal fourth-quarter earnings report. At the current market cap of
Micron Technology Inc. (NASDAQ: MU ) told investors in June to expect about $50 billion in fiscal fourth-quarter revenue. One independent research house thinks the company will beat not just that number next week, but every estimate on Wall Street. Tessara, a research platform that publishes graded forecasts, puts the
DocuSign reported Q2 revenue of $876 million, up 9% year over year, with a 32% operating margin and about $300 million in free cash flow. It also raised fiscal 2027 ARR guidance and said IAM now accounts for 15.1% of total ARR.
Peloton reports fourth-quarter revenue above analyst estimates, with adjusted EPS of 13 cents in line, and guides full-year revenue to $2.3 billion to $2.4 billion versus $2.44 billion in the prior full fiscal year.
NVIDIA Corp. (NASDAQ: NVDA) reports fiscal second-quarter results next Wednesday after the market close after a run of triple-play quarters and a recent flat stretch in the stock.
Cardiff Oncology reports Q2 EPS of $(0.14) and sales of $104,000 thousand
ONC reports $1.7B revenue
Pfizer Inc. (NYSE: PFE ) stock rose Tuesday after the drugmaker reported better-than-expected second-quarter results and raised its fiscal 2026 revenue outlook while affirming its earnings guidance. Pfizer Beats Estimates, Lifts Revenue Outlook Chairman and CEO Albert Bourla said the company’s launched and acquired pro
Japan BoJ holds rates steady at 1.0%
Boston Scientific Corporation (NYSE: BSX ) stock is trading lower after the company cut its fiscal 2026 outlook, citing pressures on the Watchman and EP markets. Q2 Beats Estimates The medical technology giant reported revenues of $5.442 billion on Wednesday, better than the consensus estimate of $5.361 billion, beatin
AstraZeneca Plc (NASDAQ: AZN ) on Monday posted mixed second-quarter 2026 results, beating Wall Street’s earnings estimates while falling short on revenue. The drugmaker also reported disappointing late-stage trial results for two experimental therapies, including a Phase 3 study of Ultomiris. AstraZeneca Beats Earning
US Ambassador: Trump Paused Attacks On Iran To Make Space For Talk Trump Holds Off On Major Escalation In Iran; Advisors Raise Concerns New Front In US-Iran War Escalates; Houthis Fire At Saudi Oil Facilities Ukraine Strikes Iranian Vessels In Caspian Sea; Tehran Vows Response US Pushes Mexico To Impose 232-Style Tarif
Reddit Inc (NYSE: RDDT ) went public in March 2024 with shares priced at $34 and a valuation of around $6 billion. Two years later the company is worth six times that and shares are up significantly. The company’s chief financial officer shares lessons learned from before and after the IPO in an exclusive interview wit
Micron Technology Inc. reports fiscal third-quarter revenue and earnings that surpass consensus estimates, prompting Bank of America to raise its price target to $1,550
Micron Technology reports quarterly results that crush expectations, with revenue of $41.46 billion and adjusted earnings per share of $25.11, beating Wall Street estimates